Английская Википедия:CP 42,096
Материал из Онлайн справочника
Шаблон:Short description Шаблон:Drugbox
CP 42,096 is an analgesic drug which acts as a cannabinoid agonist. It was developed by Pfizer in the 1980s as part of the research that led to the development of levonantradol,[1][2][3] and is more potent than THC but less potent than newer compounds such as CP 55,244.[4][5]
See also
References